BarrittDW, JordanSC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet, 1960; 1:1309–1312.
4.
BrandjesDP, HeijboerH, BüllerHR, de RijkM, JagtH, ten CateJW. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal vein thrombosis. N Engl J Med, 1992; 327:1485–1489.
5.
BelcaroG, LauroraG, CesaroneMRet al.Prevention of the extension of distal deep venous thrombosis: A randomized controlled trial with a 6 month follow up. Minerva Med, 1997; 88:507–514.
6.
LeeAY, LevineMN, BakerRIet al.Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med, 2003; 349:146–153.
7.
AklEA, BarbaM, RohillaSet al.Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst Rev, 2008; 16:CD006650.
8.
NobleSI, ShelleyMD, ColesB, WillamsSM, WilcockAW, JohnsonMJ. Management of venous thromboembolism in patients with advanced cancer: A systematic review and meta-analysis. Lancet Oncol, 2008; 9:577–584.
